Brief: China Regenerative Medicine International enters letter of intent with Retinalyze System A/S
Sept 19 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK -
* Entered into a non-legally binding letter of intent with
retinalyze system a/s
* Letter of intent for possible investments in retinalyze
system a/s
* Loi for eur3 million
Source text for Eikon: ID:nHKS3kk010
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital